TSUTOMU SAWA
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 45
- Fungal Biology and Applications 9
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 10
- Biotechnology top 2%
- Microbial Metabolism and Applications 7
- Organic Chemistry top 2%
- Carbohydrate Chemistry and Synthesis 16
- Synthesis and biological activity 10
- Microbiology top 5%
-
- Cancer therapeutics and mechanisms 18
-
- Synthesis and Biological Activity 11
- Co-authors
- TOMIO TAKEUCHIHAMAO UMEZAWAMASA HAMADAHIROSHI NAGANAWAMasaya ImotoKUNIO ISSHIKIMasaaki IshizukaHIRONOBU IINUMA
- Cited by
- PharmacologyToxicologyBiotechnology
- Journals
- Biochemical and Biophysical Research Communications (2 papers)FEBS Letters (1 paper)Journal of Natural Products (3 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
TSUTOMU SAWA
110 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 906
- Toxicology 152
- Biotechnology 307
- Organic Chemistry 888
- Microbiology 16
Countries citing papers authored by TSUTOMU SAWA
This map shows the geographic impact of TSUTOMU SAWA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TSUTOMU SAWA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TSUTOMU SAWA more than expected).
Fields of papers citing papers by TSUTOMU SAWA
This network shows the impact of papers produced by TSUTOMU SAWA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TSUTOMU SAWA. The network helps show where TSUTOMU SAWA may publish in the future.
Co-authorship network
The 25 scholars most cited alongside TSUTOMU SAWA, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 107 | |
| 2 | 2000 | 4 | |
| 3 | 1999 | 50 | |
| 4 | 1998 | 5 | |
| 5 | 1998 | 43 | |
| 6 | 1998 | 19 | |
| 7 | 1997 | 14 | |
| 8 | 1997 | 37 | |
| 9 | 1996 | 17 | |
| 10 | 1996 | 57 | |
| 11 | 1994 | 7 | |
| 12 | 1994 | 16 | |
| 13 | 1993 | 80 | |
| 14 | 1992 | 6 | |
| 15 | Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.:III. NEW ANTHRACYCLINE OBELMYCINS PRODUCED BY A VARIANT STRAIN SE2-2385 | 1991 | 2 |
| 16 | 1991 | 25 | |
| 17 | 1989 | 7 | |
| 18 | 1987 | 8 | |
| 19 | 1987 | 6 | |
| 20 | Biosynthesis of Neothramycin | 1978 | 3 |
About TSUTOMU SAWA
TSUTOMU SAWA is a scholar working on Pharmacology, Toxicology and Biotechnology, having authored 110 papers that have together received 2.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (45 papers), Cancer therapeutics and mechanisms (18 papers), Carbohydrate Chemistry and Synthesis (16 papers), Synthesis and Biological Activity (11 papers), Bioactive Compounds and Antitumor Agents (10 papers), Synthesis and biological activity (10 papers), Fungal Biology and Applications (9 papers) and Microbial Metabolism and Applications (7 papers). The work is most often cited by research in Pharmacology (906 citations), Toxicology (152 citations) and Biotechnology (307 citations). TSUTOMU SAWA has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include TOMIO TAKEUCHI, HAMAO UMEZAWA, MASA HAMADA, HIROSHI NAGANAWA, Masaya Imoto, KUNIO ISSHIKI, Masaaki Ishizuka, HIRONOBU IINUMA, Kazuo Umezawa and Senji Hori. Their work appears in journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.